EKSO Stock Analysis: Buy, Sell, or Hold?
EKSO - Ekso Bionics Holdings, Inc. Common Stock
$9.40
-1.25 (-11.74%)
▼
5d:
-13.76%
30d:
-11.82%
90d:
+8.8%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When EKSO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: EKSO is down 13.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: EKSO is down 13.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: EKSO is currently trading at $9.40, which is considered oversold relative to its 30-day fair value range of $9.98 to $11.50.
Technical Outlook: Technically, EKSO is in a strong uptrend. The price is currently testing key support at $9.70. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EKSO is in a strong uptrend. The price is currently testing key support at $9.70. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$9.98 -
$11.50
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.7%)
- NEUTRAL: Near Wall St target ($9.50)
- WARNING: Recommendation downgraded due to -13.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$9.98 -
$11.50
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$9.70
Resistance Level
$11.60
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-134.29
Wall Street Target
$9.50
(+1.1%)
Revenue Growth (YoY)
-38.3%
Profit Margin
-91.4%
Share & Embed Analysis
Last updated: April 02, 2026 5:30 PM ET
Data refreshes hourly during market hours. Next update: 6:30 PM
Data refreshes hourly during market hours. Next update: 6:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EKSO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Daniel Asher
BUY
15540 shares
2026-02-19
Jerome Wong
SELL
11288 shares
2025-11-10
Scott G Davis
SELL
23315 shares
2025-11-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 60 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 61 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 65 BUY |
